Leo, "If clinical trials show that Kevetrin restores damaged RB and P-53 in humans to their normal tumor surpressing status, it could be one of the greatest breakthroughs in cancer history. Kevetrin is thoroughly protected through pending patents which cover tens of thousands of possible future chemical combinations for new drugs, a potentially very valuable proposition for multiple drug developments in the future."